Foley M, Carney T, Harris R, Fitzpatrick E, Rapca-Veillet A, Van Hout M C
School of Health Science, Waterford Institute of Technology, Waterford, Ireland.
Tobacco and Other Drug Research Unit, South African Medical Research Council, Cape Town, South Africa.
Ir J Med Sci. 2017 Aug;186(3):555-563. doi: 10.1007/s11845-016-1546-z. Epub 2017 Jan 9.
The aim of the study was to examine prescribing professional's perceptions on prescribed and OTC medicines, containing codeine in the Republic of Ireland. A secondary aim was to examine perceptions on codeine dependence, screening and treatment.
A cross-sectional study of a nationally representative group of prescribing professionals was conducted using a questionnaire containing a number of open and closed ended items. Data were analysed using SPSS version 21 and content analysis techniques.
398 medical professionals participated in the study giving a response rate of 18%. 77% of respondents agreed to routinely review patient prescribed codeine. 59% of respondents routinely asked patients about their use of OTC medicines and 50% documented use of OTC codeine in their patients' medical notes. 93% indicated concern about the potential to purchase codeine from multiple sources. 88% implied that patients did not fully understand the risks of taking OTC medicine containing codeine. Only 21% of respondents were confident in identifying codeine dependence without being informed by the patient and 11.4% agreed to have suitable screening methods in practice. 76% indicated that they would like more instruction on prescribing addictive medicines.
Policy should examine the need for greater public health awareness on codeine use and should examine the role of OTC and internet sales in the development of dependence. Further consideration should be given to training and support for those who prescribe addictive medicines in practice.
本研究旨在调查爱尔兰共和国开具处方的专业人员对含可待因的处方药和非处方药的看法。次要目的是调查对可待因依赖、筛查和治疗的看法。
采用包含多个开放式和封闭式问题的问卷,对具有全国代表性的开具处方专业人员群体进行横断面研究。使用SPSS 21版软件和内容分析技术对数据进行分析。
398名医学专业人员参与了研究,回复率为18%。77%的受访者同意定期审查患者开具的可待因处方。59%的受访者会定期询问患者使用非处方药的情况,50%的受访者会在患者病历中记录非处方可待因的使用情况。93%的受访者表示担心从多个渠道购买可待因的可能性。88%的受访者暗示患者没有完全理解服用含可待因非处方药的风险。只有21%的受访者有信心在患者未告知的情况下识别可待因依赖,11.4%的受访者同意在实际操作中有合适的筛查方法。76%的受访者表示希望获得更多关于开具成瘾性药物的指导。
政策应审视提高公众对可待因使用的健康意识的必要性,并应审视非处方药和网络销售在成瘾发展中的作用。应进一步考虑为实际开具成瘾性药物的人员提供培训和支持。